575 Preclinical characterization of LAE111, a potent anti-LILRB1/LILRB2 antagonist bispecific antibody

• Rong Wu,
• Xiang-Ju Justin Gu,
• Minhua Zhang,
• Chaojun Cai

Affiliations

Rong Wu

Department of Periodontology, Peking University, School of Stomatology, Beijing, China

Xiang-Ju Justin Gu

Laekna Therapeutics, Shanghai, China

Minhua Zhang

Laekna Therapeutics, Shanghai, China

Chaojun Cai

Laekna Therapeutics, Shanghai, China